Pharmacological considerations of primary alkylators.

Cancer treatment and research

Volumn 112, Issue , 2002, Pages 323-345

  McCune, Jeannine S ^a   Slattery, John T ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ANTINEOPLASTIC AGENT; BUSULFAN; CARBOPLATIN; CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; IFOSFAMIDE; THIOTEPA;

HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; REVIEW;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, ALKYLATING; BUSULFAN; CARBOPLATIN; CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IFOSFAMIDE; THIOTEPA;

MLCS; MLOWN;

EID: 1842844017     PISSN: 09273042     EISSN: None     Source Type: Journal    
DOI: 10.1007/978-1-4615-1173-1_16     Document Type: Review

References (98)